Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Sunday, October 8, 2023
  • 7:00 AM - 6:00 PM EDT
    Registration
  • 7:15 AM - 8:15 AM EDT
    Breakfast Coffee & Tea
  • 8:15 AM - 9:55 AM EDT
    Session 5: Optimizing Initial Therapy of CLL
    Co-Chair: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute (DFCI)
    Co-Chair: Mazyar Shadman, MD, MPH – Fred Hutchinson Cancer Center / University of Washington School of Medicine
  • 9:55 AM - 10:20 AM EDT
    Morning Break
  • 10:20 AM - 11:20 AM EDT
    Industry Supported Symposium: Chronic Lymphocytic Leukemia: Applying the Latest Evidence With BTK Inhibitors to Clinical Decision-Making
  • 11:20 AM - 12:55 PM EDT
    Session 6: Mechanisms of Resistance
    Co-Chair: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University
    Co-Chair: Marek Mraz, MD, PhD – CEITEC MU, Brno, Czech Rep.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University
  • 12:55 PM - 1:45 PM EDT
    Lunch
  • 1:45 PM - 2:45 PM EDT
    Industry Supported Symposium: Partnerships in CLL: Evolving Patient Goals and Treatment Considerations
  • 2:45 PM - 4:10 PM EDT
    Session 7: Future Directions for the Treatment of Relapsed/Refractory CLL
    Co-Chair: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam
    Co-Chair: Danielle M. Brander, MD – Duke University Medical Center
  • 4:10 PM - 4:20 PM EDT
    Binet/Rai Medal Presentation
  • 4:30 PM - 6:30 PM EDT
    Wine & Cheese Poster Session Reception